Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel, Cisplatin, and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
NCT00155259Phase 2Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Oct 2004
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, cisplatin, capecitabine in breast cancer, sponsored by National Taiwan University Hospital. Started Oct 2004; status: completed.
02
Drugs
docetaxelcisplatincapecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00155259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00155259.